PLEA was launched in May this year and is already reaching and supporting hundreds of people across the UK fighting to gain access to the medication they so desperately need.
A WORLD-LEADING cannabis professor says the UK is caught in a depressing Catch-22 with companies unwilling to invest in clinical trials and medics unwilling to rely on real-world patient data.
ONE of the UK’s first market-listed medical cannabis and CBD companies has been sold to Canadian producer Stillcanna for over £10m.
MEDICINAL cannabis prescribing could be handed over to the UK’s private clinics in a move which would free up access for tens of thousands of patients.
